327 related articles for article (PubMed ID: 31413125)
1. CRISPR/Cas9-Mediated Knockout and
BeltCappellino A; Majerciak V; Lobanov A; Lack J; Cam M; Zheng ZM
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413125
[TBL] [Abstract][Full Text] [Related]
2.
Kang SK; Kang YH; Yoo SM; Park C; Kim HS; Lee MS
J Virol; 2021 Jul; 95(16):e0079921. PubMed ID: 34105998
[TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus.
Majerciak V; Pripuzova N; McCoy JP; Gao SJ; Zheng ZM
J Virol; 2007 Feb; 81(3):1062-71. PubMed ID: 17108026
[TBL] [Abstract][Full Text] [Related]
4. Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein.
Verma D; Li DJ; Krueger B; Renne R; Swaminathan S
J Virol; 2015 Feb; 89(3):1688-702. PubMed ID: 25410858
[TBL] [Abstract][Full Text] [Related]
5. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Gutierrez IV; Dayton J; Harger S; Rossetto CC
J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
[TBL] [Abstract][Full Text] [Related]
6. Reversible switching of primary cells between normal and malignant state by oncogenic virus KSHV and CRISPR/Cas9-mediated targeting of a major viral latent protein.
Ju E; Li T; Ramos da Silva S; Markazi A; Gao SJ
J Med Virol; 2021 Aug; 93(8):5065-5075. PubMed ID: 33942339
[TBL] [Abstract][Full Text] [Related]
7. HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma-associated herpesvirus ORF57 protein and host pre-mRNA metabolism.
Sei E; Wang T; Hunter OV; Xie Y; Conrad NK
PLoS Pathog; 2015 Feb; 11(2):e1004652. PubMed ID: 25710169
[TBL] [Abstract][Full Text] [Related]
8. Protein-RNA Interactome Analysis Reveals Wide Association of Kaposi's Sarcoma-Associated Herpesvirus ORF57 with Host Noncoding RNAs and Polysomes.
Alvarado-Hernandez B; Ma Y; Sharma NR; Majerciak V; Lobanov A; Cam M; Zhu J; Zheng ZM
J Virol; 2022 Feb; 96(3):e0178221. PubMed ID: 34787459
[TBL] [Abstract][Full Text] [Related]
9. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
Tso FY; West JT; Wood C
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
Liang Z; Qin Z; Riker AI; Xi Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
[TBL] [Abstract][Full Text] [Related]
11. ORF57 overcomes the detrimental sequence bias of Kaposi's sarcoma-associated herpesvirus lytic genes.
Vogt C; Hackmann C; Rabner A; Koste L; Santag S; Kati S; Mandel-Gutfreund Y; Schulz TF; Bohne J
J Virol; 2015 May; 89(9):5097-109. PubMed ID: 25694606
[TBL] [Abstract][Full Text] [Related]
12. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.
Zhou FC; Zhang YJ; Deng JH; Wang XP; Pan HY; Hettler E; Gao SJ
J Virol; 2002 Jun; 76(12):6185-96. PubMed ID: 12021352
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
Roy A; Dutta D; Iqbal J; Pisano G; Gjyshi O; Ansari MA; Kumar B; Chandran B
J Virol; 2016 Oct; 90(19):8822-41. PubMed ID: 27466416
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter.
Elbasani E; Falasco F; Gramolelli S; Nurminen V; Günther T; Weltner J; Balboa D; Grundhoff A; Otonkoski T; Ojala PM
Viruses; 2020 Aug; 12(9):. PubMed ID: 32867368
[TBL] [Abstract][Full Text] [Related]
15. CLIP-seq to Identify KSHV ORF57-Binding RNA in Host B Cells.
Ma Y; Liu P; Majerciak V; Zhu J; Zheng ZM
Curr Protoc Microbiol; 2016 May; 41():1E.11.1-1E.11.18. PubMed ID: 27153386
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Kaposi's sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells.
Haddad CO; Kalt I; Shovman Y; Xia L; Schlesinger Y; Sarid R; Parnas O
Virol J; 2021 Mar; 18(1):56. PubMed ID: 33731154
[TBL] [Abstract][Full Text] [Related]
17. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production.
Han Z; Swaminathan S
J Virol; 2006 Jun; 80(11):5251-60. PubMed ID: 16699005
[TBL] [Abstract][Full Text] [Related]
20. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
Li Q; He M; Zhou F; Ye F; Gao SJ
J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
